STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 3] DBV Technologies S.A. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

DBV Technologies S.A. (DBVT) reported an insider ownership update via Form 3. The reporting person, who serves as Chief Commercial Officer, filed as a single reporting person and stated no securities are beneficially owned. The event date is 11/03/2025. This filing establishes the officer’s initial ownership position, indicating no non-derivative or derivative holdings at the time referenced.

Positive
  • None.
Negative
  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Trapp Kevin Michael

(Last) (First) (Middle)
C/O DBV TECHNOLOGIES S.A.
107 AVENUE DE LA REPUBLIQUE

(Street)
CHATILLON I0 92320

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
11/03/2025
3. Issuer Name and Ticker or Trading Symbol
DBV Technologies S.A. [ DBVT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Commercial Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
No securities are beneficially owned.
/s/ Virginie Boucinha, Attorney-in Fact 11/12/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DBVT’s Form 3 disclose?

It disclosed that the Chief Commercial Officer reported no securities beneficially owned.

What is the date of the event on DBVT’s Form 3?

The event date is 11/03/2025.

Who is the reporting person on this Form 3 for DBVT?

A single reporting person serving as Chief Commercial Officer filed the form.

Does the Form 3 show any non-derivative or derivative holdings for DBVT?

No. The explanation states No securities are beneficially owned.

Is the DBVT Form 3 a joint filing?

No. It was filed by one reporting person.

What is the issuer name and ticker in this filing?

The issuer is DBV Technologies S.A. with ticker DBVT.
Dbv Technologies S A

NASDAQ:DBVT

DBVT Rankings

DBVT Latest News

DBVT Latest SEC Filings

DBVT Stock Data

469.49M
35.75M
5.3%
0.07%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
France
CHATILLON